• Live Feeds
    • Press Releases
    • Insider Trading
    • FDA Approvals
    • Analyst Ratings
    • Insider Trading
    • SEC filings
    • Market insights
  • Analyst Ratings
  • Alerts
  • Subscriptions
  • Settings
  • RSS Feeds
Quantisnow Logo
  • Live Feeds
    • Press Releases
    • Insider Trading
    • FDA Approvals
    • Analyst Ratings
    • Insider Trading
    • SEC filings
    • Market insights
  • Analyst Ratings
  • Alerts
  • Subscriptions
  • Settings
  • RSS Feeds
PublishGo to App
    Quantisnow Logo

    © 2026 quantisnow.com
    Democratizing insights since 2022

    Services
    Live news feedsRSS FeedsAlertsPublish with Us
    Company
    AboutQuantisnow PlusContactJobsAI superconnector for talent & startupsNEWLLM Arena
    Legal
    Terms of usePrivacy policyCookie policy

    12 Health Care Stocks Moving In Wednesday's After-Market Session

    8/23/23 5:32:28 PM ET
    $ACON
    $AKAN
    $BFRG
    $EHAB
    Medical Specialities
    Health Care
    Medicinal Chemicals and Botanical Products
    Health Care
    Get the next $ACON alert in real time by email

    Gainers

    • Enhabit (NYSE:EHAB) stock increased by 8.2% to $12.92 during Wednesday's after-market session. The company's market cap stands at $647.3 million.
    • Scilex Holding (NASDAQ:SCLX) stock increased by 7.76% to $3.33. The company's market cap stands at $496.3 million.
    • Bullfrog AI Hldgs (NASDAQ:BFRG) stock increased by 7.59% to $3.54. Bullfrog AI Hldgs's trading volume hit 51.3K shares by close, accounting for 4.2% of its average volume over the last 100 days. The company's market cap stands at $21.5 million.
    • Nemaura Medical (NASDAQ:NMRD) stock moved upwards by 7.31% to $0.44. The company's market cap stands at $12.7 million.
    • NightHawk Biosciences (AMEX:NHWK) stock rose 6.25% to $0.68. The market value of their outstanding shares is at $17.7 million.
    • Akanda (NASDAQ:AKAN) stock moved upwards by 6.22% to $0.51. The market value of their outstanding shares is at $1.9 million.

    Losers

    • Societal CDMO (NASDAQ:SCTL) stock declined by 26.0% to $0.45 during Wednesday's after-market session. The company's market cap stands at $40.5 million.
    • Kiora Pharmaceuticals (NASDAQ:KPRX) shares decreased by 8.88% to $0.57. Today's trading volume for this security ended up closing at 5.3 million shares, which is 1948.3 percent of its average volume over the last 100 days. The company's market cap stands at $4.1 million.
    • G Medical Innovations (NASDAQ:GMVD) shares decreased by 8.84% to $0.17. Today's trading volume for this security ended up closing at 742.3K shares, which is 59.9 percent of its average volume over the last 100 days. The company's market cap stands at $1.6 million.
    • Aclarion (NASDAQ:ACON) shares decreased by 6.51% to $0.43. The company's market cap stands at $3.5 million.
    • Reshape Lifesciences (NASDAQ:RSLS) shares decreased by 6.31% to $1.12. The market value of their outstanding shares is at $3.8 million.
    • InspireMD (NASDAQ:NSPR) stock declined by 5.61% to $3.2. The company's market cap stands at $67.8 million. See Also: www.benzinga.com/money/best-healthcare-stocks/

    This article was generated by Benzinga's automated content engine and reviewed by an editor.

    Get the next $ACON alert in real time by email

    Crush Q1 2026 with the Best AI Superconnector

    Stay ahead of the competition with Standout.work - your AI-powered talent-to-startup matching platform.

    AI-Powered Inbox
    Context-aware email replies
    Strategic Decision Support
    Get Started with Standout.work

    Recent Analyst Ratings for
    $ACON
    $AKAN
    $BFRG
    $EHAB

    CompanyDatePrice TargetRatingAnalyst
    Enhabit Inc.
    $EHAB
    3/6/2026$13.80Buy → Hold
    TD Cowen
    InspireMD Inc.
    $NSPR
    2/2/2026$6.00Buy
    Maxim Group
    Enhabit Inc.
    $EHAB
    1/22/2026$14.00Perform → Outperform
    Oppenheimer
    Enhabit Inc.
    $EHAB
    1/13/2026$12.00Hold → Buy
    TD Cowen
    Enhabit Inc.
    $EHAB
    1/8/2026$12.00Neutral → Buy
    UBS
    Enhabit Inc.
    $EHAB
    1/7/2026$10.50Hold
    Truist
    Scilex Holding Company
    $SCLX
    1/27/2025$22.00Buy
    D. Boral Capital
    Enhabit Inc.
    $EHAB
    12/9/2024$8.25 → $9.50Hold → Buy
    Jefferies
    More analyst ratings

    $ACON
    $AKAN
    $BFRG
    $EHAB
    Press Releases

    Fastest customizable press release news feed in the world

    View All

    InspireMD to Participate in Upcoming 25th Annual Needham Virtual Healthcare Conference

    MIAMI, March 31, 2026 (GLOBE NEWSWIRE) -- InspireMD, Inc. (NASDAQ:NSPR), developer of the CGuard® Prime carotid stent system for the prevention of stroke, today announced plans to present at the upcoming 25th Annual Needham Virtual Healthcare Conference on Tuesday, April 14th at 12:45 pm Eastern Time (ET). A live audio webcast and an archive of the recording will be available through the Investors page of InspireMD's corporate website at https://investors.inspiremd.com. About InspireMD, Inc.InspireMD seeks to utilize its proprietary MicroNet™ mesh technology to make its products the industry standard for carotid stenting by providing outstanding acute results and durable, stroke-free lon

    3/31/26 4:05:00 PM ET
    $NSPR
    Medical/Dental Instruments
    Health Care

    BullFrog AI Announces Commercial Agreement with Top 5 Global Pharmaceutical Company to Identify and Prioritize Therapeutic Target in Major Depressive Disorder

    Commercial agreement serves as high-profile third party validation of BullFrog AI's proprietary capabilities Agreement utilizes BullFrog AI's end-to-end analytical AI platform to accelerate drug discovery and development program  GAITHERSBURG, Md., March 30, 2026 (GLOBE NEWSWIRE) -- BullFrog AI Holdings, Inc. (NASDAQ:BFRG, BFRGW)) ("BullFrog AI" or the "Company"), a technology company using artificial intelligence ("AI") and machine learning to turn complex biomedical data into actionable insights, today announced a commercial agreement with a top 5 global pharmaceutical company in 2025 by revenue ("Customer"), to apply the Company's proprietary bfLEAP® platform to identify and prioritize

    3/30/26 7:30:00 AM ET
    $BFRG
    Biotechnology: Pharmaceutical Preparations
    Health Care

    Akanda Corp. Driving Recurring Revenue Growth: $2 Million Cash Flow Secured Through Fiber Acquisition

    Toronto, Ontario--(Newsfile Corp. - March 26, 2026) - Akanda Corp. (NASDAQ:AKAN) ("Akanda") and its wholly owned subsidiary, First Towers & Fiber Corp. ("FTF" or the "Company"), an emerging telecommunications infrastructure developer in Mexico, are pleased to announce an expansion of its dark fiber network with the addition of approximately 200 kilometres, increasing total network coverage to approximately 900 kilometres across Central Mexico.This milestone is expected to materially advance FTF's strategy to build a scaled, high-margin, cash-flow-generating digital infrastructure platform in what the Company believes is one of Latin America's most attractive and undersupplied connectivity ma

    3/26/26 8:30:00 AM ET
    $AKAN
    Medicinal Chemicals and Botanical Products
    Health Care

    $ACON
    $AKAN
    $BFRG
    $EHAB
    Insider Trading

    Insider transactions reveal critical sentiment about the company from key stakeholders. See them live in this feed.

    View All

    SEC Form 4 filed by Tosca Melissa

    4 - KIORA PHARMACEUTICALS INC (0001372514) (Issuer)

    4/2/26 4:47:03 PM ET
    $KPRX
    Biotechnology: Pharmaceutical Preparations
    Health Care

    SEC Form 4 filed by Daniels Eric Joseph

    4 - KIORA PHARMACEUTICALS INC (0001372514) (Issuer)

    4/2/26 4:46:14 PM ET
    $KPRX
    Biotechnology: Pharmaceutical Preparations
    Health Care

    SEC Form 4 filed by Strem Brian M.

    4 - KIORA PHARMACEUTICALS INC (0001372514) (Issuer)

    4/2/26 4:45:32 PM ET
    $KPRX
    Biotechnology: Pharmaceutical Preparations
    Health Care

    $ACON
    $AKAN
    $BFRG
    $EHAB
    Insider Purchases

    Insider purchases reveal critical bullish sentiment about the company from key stakeholders. See them live in this feed.

    View All

    Amendment: Director Stuka Paul bought $4,905 worth of shares (2,710 units at $1.81), increasing direct ownership by 0.70% to 391,628 units (SEC Form 4)

    4/A - InspireMD, Inc. (0001433607) (Issuer)

    2/23/26 4:05:19 PM ET
    $NSPR
    Medical/Dental Instruments
    Health Care

    Large owner Hrt Financial Lp bought $40,650 worth of Class A Shares (29,036 units at $1.40) and sold $10,150 worth of Class A Shares (7,868 units at $1.29) (SEC Form 4)

    4 - AKANDA CORP. (0001888014) (Issuer)

    1/20/26 2:07:19 PM ET
    $AKAN
    Medicinal Chemicals and Botanical Products
    Health Care

    Director Stuka Paul bought $9,182 worth of shares (5,073 units at $1.81), increasing direct ownership by 1% to 391,628 units (SEC Form 4)

    4 - InspireMD, Inc. (0001433607) (Issuer)

    12/11/25 4:05:09 PM ET
    $NSPR
    Medical/Dental Instruments
    Health Care

    $ACON
    $AKAN
    $BFRG
    $EHAB
    SEC Filings

    View All

    SEC Form PRE 14A filed by Aclarion Inc.

    PRE 14A - Aclarion, Inc. (0001635077) (Filer)

    4/3/26 5:02:23 PM ET
    $ACON
    Medical Specialities
    Health Care

    InspireMD Inc. filed SEC Form 8-K: Entry into a Material Definitive Agreement

    8-K - InspireMD, Inc. (0001433607) (Filer)

    4/3/26 4:01:06 PM ET
    $NSPR
    Medical/Dental Instruments
    Health Care

    SEC Form 424B5 filed by InspireMD Inc.

    424B5 - InspireMD, Inc. (0001433607) (Filer)

    4/3/26 3:53:53 PM ET
    $NSPR
    Medical/Dental Instruments
    Health Care

    $ACON
    $AKAN
    $BFRG
    $EHAB
    Analyst Ratings

    Analyst ratings in real time. Analyst ratings have a very high impact on the underlying stock. See them live in this feed.

    View All

    Enhabit Inc. downgraded by TD Cowen with a new price target

    TD Cowen downgraded Enhabit Inc. from Buy to Hold and set a new price target of $13.80

    3/6/26 8:25:46 AM ET
    $EHAB
    Medical/Nursing Services
    Health Care

    Maxim Group initiated coverage on InspireMD with a new price target

    Maxim Group initiated coverage of InspireMD with a rating of Buy and set a new price target of $6.00

    2/2/26 7:53:56 AM ET
    $NSPR
    Medical/Dental Instruments
    Health Care

    Enhabit Inc. upgraded by Oppenheimer with a new price target

    Oppenheimer upgraded Enhabit Inc. from Perform to Outperform and set a new price target of $14.00

    1/22/26 8:46:17 AM ET
    $EHAB
    Medical/Nursing Services
    Health Care

    $ACON
    $AKAN
    $BFRG
    $EHAB
    Leadership Updates

    Live Leadership Updates

    View All

    Scilex Holding Company Appoints Kasowitz LLP as Litigation and Intellectual Property Counsel

    PALO ALTO, Calif., Jan. 02, 2026 (GLOBE NEWSWIRE) -- Scilex Holding Company ("Scilex" or the "Company") (NASDAQ:SCLX), an innovative revenue-generating company focused on acquiring, developing and commercializing non-opioid pain management products for the treatment of acute and chronic pain and neurodegenerative and cardiometabolic disease, announced that it has appointed Kasowitz LLP and its founding partner Marc Kasowitz as the Company's litigation and intellectual property counsel. Kasowitz LLP will advise Scilex on complex commercial litigation, patent litigation, intellectual property enforcement and defense, licensing matters, and strategic intellectual property governance as the C

    1/2/26 9:00:00 AM ET
    $SCLX
    Biotechnology: Biological Products (No Diagnostic Substances)
    Health Care

    Aclarion Appoints Jason Brosniak as Commercial Director to Drive Adoption and Market Expansion in the Eastern U.S.

    Proven commercial leader with 20+ years of experience driving revenue growth and market adoption for early-stage and high-growth MedTech companiesStrong track record of launching breakthrough technologies across spine, neurosurgery and pain managementStrengthens Aclarion's commercial execution as the Company expands adoption and payer engagement across the Eastern U.S. BROOMFIELD, Colo., Dec. 02, 2025 (GLOBE NEWSWIRE) -- Aclarion, Inc., ("Aclarion" or the "Company") (NASDAQ:ACON, ACONW)), a healthcare technology company that is leveraging biomarkers and proprietary augmented intelligence (AI) algorithms to help physicians identify the location of chronic low back pain, today announced the

    12/2/25 8:00:00 AM ET
    $ACON
    Medical Specialities
    Health Care

    Aclarion Appoints Dan Isherwood as UK Commercial Director to Drive Adoption and Market Expansion

    Marks Aclarion's first commercial sales hire with seasoned HealthTech leader and proven track record of advancing musculoskeletal imaging and spinal surgeryExperiencing strong commercial traction in UK as first market worldwide with private insurers covering NociscanNociscan reimbursed by three of top four private insurers in UK, giving access to more than 5.2 million covered lives BROOMFIELD, Colo., Nov. 05, 2025 (GLOBE NEWSWIRE) -- Aclarion, Inc. ("Aclarion" or the "Company") (NASDAQ:ACON, ACONW)), a healthcare technology company that is leveraging biomarkers and proprietary augmented intelligence (AI) algorithms to help physicians identify the location of chronic low back pain, announc

    11/5/25 6:00:00 AM ET
    $ACON
    Medical Specialities
    Health Care

    $ACON
    $AKAN
    $BFRG
    $EHAB
    Large Ownership Changes

    This live feed shows all institutional transactions in real time.

    View All

    SEC Form SC 13G filed by InspireMD Inc.

    SC 13G - InspireMD, Inc. (0001433607) (Subject)

    12/4/24 4:31:06 PM ET
    $NSPR
    Medical/Dental Instruments
    Health Care

    SEC Form SC 13G filed by Enhabit Inc.

    SC 13G - Enhabit, Inc. (0001803737) (Subject)

    11/14/24 9:12:39 PM ET
    $EHAB
    Medical/Nursing Services
    Health Care

    Amendment: SEC Form SC 13G/A filed by Kiora Pharmaceuticals Inc.

    SC 13G/A - KIORA PHARMACEUTICALS INC (0001372514) (Subject)

    11/14/24 7:17:24 PM ET
    $KPRX
    Biotechnology: Pharmaceutical Preparations
    Health Care

    $ACON
    $AKAN
    $BFRG
    $EHAB
    Financials

    Live finance-specific insights

    View All

    Aclarion, Inc. Adopts Limited Duration Stockholder Rights Plan

    BROOMFIELD, Colo., March 19, 2026 (GLOBE NEWSWIRE) -- Aclarion, Inc. (NASDAQ:ACON, ACONW)) ("Aclarion" or the "Company") today announced that its Board of Directors (the "Board") has unanimously adopted a limited duration stockholder rights plan (the "Rights Plan"). The Rights Plan is effective immediately and expires in one year. The Rights Plan is intended to enable all stockholders to realize the long-term value of their investment in Aclarion. The Rights Plan is also intended to reduce the likelihood that any person or group gains control of the Company without paying all stockholders an appropriate control premium. The Rights Plan will help to ensure the Board has sufficient time to

    3/19/26 9:25:40 AM ET
    $ACON
    Medical Specialities
    Health Care

    InspireMD Reports Fourth Quarter and Full Year 2025 Financial Results

    MIAMI, March 18, 2026 (GLOBE NEWSWIRE) -- InspireMD, Inc. (NASDAQ:NSPR) ("InspireMD" or the "Company"), developer of the CGuard® Prime carotid stent system for the prevention of stroke, today announced financial and operating results for the fourth quarter and year ended December 31, 2025. Recent Business Highlights: Generated revenue of $3.1 million in the fourth quarter of 2025, up 62% year-over-year.Sustained strong commercial traction in the U.S. with the launch of CGuard Prime and continued growth in international demand for CGuard.Supported over 500 cumulative carotid procedures utilizing CGuard Prime across leading hospitals and integrated delivery networks since launch.Co

    3/18/26 7:00:00 AM ET
    $NSPR
    Medical/Dental Instruments
    Health Care

    InspireMD to Announce Fourth Quarter and Full Year 2025 Financial Results

    MIAMI, March 09, 2026 (GLOBE NEWSWIRE) -- InspireMD, Inc. (NASDAQ:NSPR), developer of the CGuard® Prime carotid stent system for the prevention of stroke, today announced that it will release its fourth quarter and full year 2025 financial results on Wednesday, March 18, 2026. In conjunction with the release, InspireMD will host a conference call and webcast at 8:30 a.m. Eastern Time to discuss its financial results and recent highlights. A live audio webcast and an archive of the recording will be available through the Investors page of InspireMD's corporate website at https://investors.inspiremd.com. Interested participants are encouraged to register more than 15 minutes before the star

    3/9/26 9:00:00 AM ET
    $NSPR
    Medical/Dental Instruments
    Health Care